¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"zinc sulfate flotation centrifugation method"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • graphic method
    ±×·¡ÇÁ¹ý, ¼±µµ¹ý
  • gravimetric method
    Áß·®¹ý
  • high flow method
    °íÀ¯·®¹ý
  • homozygous typing method
    µ¿Á¾Á¢ÇÕÇüº°ÆÇº°¹ý
  • hanging drop method
    ÇöÀû¹ý
  • introspective method
    ³»¼º¹ý
  • isodose shift method
    µî¼±·®À̵¿¹ý
  • immersion method
    ¼öħ¹ý
  • immunodiagnostic method
    ¸é¿ªÁø´Ü¹ý
  • impression method
    Àλó¹ý
  • indicator dilution method
    Áö½Ã¾àÈñ¼®¹ý
  • infrared absorption method
    Àû¿Ü¼±Èí¼ö¹ý
  • injection molding method
    »çÃ⼺Çü¹ý
  • intracorporeal method
    ü³»¹ý
  • limiting dilution method
    ÇѰèÈñ¼®¹ý
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • gasometric method
    °¡½ºÁ¤·®¹ý
  • gradient method
    °è´ÜÀû°Ë»ç¹ý
  • graphic method
    ±×·¡ÇÁ¹ý, ¼±µµ¹ý
  • gravimetric method
    Áß·®¹ý
  • hanging drop method
    ÇöÀû¹ý
  • high flow method
    °íÀ¯·®¹ý
  • homozygous typing method
    µ¿ÇüÁ¢ÇÕ¼ºÇüº°ÆÇº°¹ý
  • immersion method
    ¼öħ¹ý
  • immunodiagnostic method
    ¸é¿ªÁø´Ü¹ý
  • impression method
    Àλó¹ý
  • India ink method
    ¸Ô¹°°æ°Ë¹ý, ¸Ô¹°¹ý
  • indicator dilution method
    Áö½Ã¾àÈñ¼®¹ý
  • indirect direct method
    °£Á¢Á÷Á¢¹ý
  • infrared absorption method
    Àû¿Ü¼±Èí¼ö¹ý
  • injection cast corrosion method
    Ç÷°üÁÖÇüÀÛÁ¦¹ý
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • infrared absorption method
    È£±â°¡½ººÐ¼®½Ã Àû¿Ü¼± Èí¼ö¹ý
  • injection cast corrosion method
    Ç÷°üÁÖÇüÀÛÁ¦¹ý.
  • injection molding method
    »çÃ⼺Çü¹ý(ÞÒõóà÷úþÛö).
  • pisano method
    ÇÇ»ç³ë¹æ¹ý
  • plate dilution (method)
    ÆòÆÇÈñ¼®¹ý(øÁ÷ù ýüà·Ûö).
  • plating method
    ÆòÆÇ¹è¾ç¹ý
  • pour plate [method]
    ºÎ¾î½É±âÆòÆÇ(¹è¾ç¹ý)
  • precipitation method
    ħÀü¹ý( îþÛö) ÀûÁ¤(îÙïá)ÀÇ .
  • presaturation method
    Àü Æ÷È­¹ý
  • provocation method
    À¯¹ß½ÃÇè¹ý(¡­ãËúÐÛö).
  • pulse method
    ÆÞ½º¹ý
  • pulse spray method
    ¸Æµ¿ »ìÆ÷¹ý
  • radioactive tracer method
    ¹æ»ç´ÉÃßÀû¹ý
  • radioisotope renal clearance method
    ¹æ»ç¼º µ¿À§¿ø¼Ò¼º ½ÅÁ¦°ÅÀ²ÃøÁ¤¹ý(¡­ê« áÈàõãìð¶ËÛëÒö´ïÒÛö).
  • rapid detection method
    Á¶±â°ËÃâ()¹æ¹ý
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • alkaline phosphatase antialkaline phophatase method
    ¾ËÄ®¸®¼º Æ÷½ºÆÄŸÁ¦ Ç×¾ËÄ®¸®¼º Æ÷½ºÆÄŸÁ¦¹ý
  • allochromatic method
    º¯»ö¹ý.
  • alternate case method
    ±³´ëȯÀÚ¿ä¹ý.
  • alternate paired case method
    ±³´ë´ë¸³È¯ÀÚ¿ä¹ý(ÎßÓÛÓßí¡ü´íºèþÛö).
  • analytical method
    ºÐ¼®¹ý
  • ascending method
    »ó½Â¹ý
  • aspirative irrigation method
    ÈíÀμ¼Ã´¹ý.
  • auscultatory method
    ûÁø¹ý.
  • bidiazotized benzidine method
    ¹ÙÀ̵ð¾ÆÁ¶È­º¥Áöµò¹ý
  • bioassay method
    »ý¹°ÇÐÀû °ËÁ¤¹ý(¡­ËþïÒÛö).
  • bioassay method
    »ý¹°ÇÐÀû °ËÁ¤¹ý(ÊÙË§ËøËÑ).
  • bisecting method
    À̵îºÐ¸é¹ý(¡­ÝÂØüÛö).
  • biuret method
    ºä·¿(¹æ)¹ý
  • bleaching method of discolored teeth
    º¯»öġǥ¹é¹ý(ܨßäöÍø÷ÛÜÛö).
  • bolus-tracking method
    µ¢¾î¸® ÃßÀû ¹æ¹ý
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • heavy atom method
    Áß¿øÀÚ¹ý(ñìê«í­Ûö)
  • high-temperature-short-time method
    °í¿Â ´Ü½Ã°£¹ý(ÍÔè®Ó­ãÁÊàÛö)
  • isotope derivative method
    µ¿À§¿ø¼ÒÀ¯µµÃ¼¹ý(ÔÒêÈêªáÈë¯Óôô÷Ûö)
  • jump method
    ¶Ù±â ¹æ¹ý(Û°Ûö)
  • Kjeldahl method
    Ű¿¤´Þ¹ý(Ûö)
  • label triangulation method
    Ç¥Áö»ï°¢È­¹ý(øöò½ß²ÊÇûùÛö)
  • Lowry method
    ·Î¿ì¸®¹ý(Ûö)
  • low-temperature heat method
    Àú¿Â¿­¹ý(î¸è®æðÛö)
  • LTH method
    LTH¹ý(Ûö)
  • matrix method
    ¸ÅÆ®¸¯½º¹ý(Ûö)
  • Maxam-Gilbert method
    ¸·»ï-±æ¹öÆ®¹ý(Ûö)
  • maximum height-area method
    Ãִ뱤¿ª¹ý(õÌÓÞÎÆæ´Ûö)
  • Merrifield method
    ¸Þ¸®Çʵå¹ý(Ûö)
  • method of continuous variation
    ¿¬¼Óº¯È­¹ý(Ö§áÙܨûùÛö)
  • method of optimal proportions
    ÀûÁ¤ºÎºÐ¹ý(îêïÒÝ»ÝÂÛö)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 6
ZCP zinc chloride poisoning
ZD zero defects; zero discharge; zinc deficiency
ZDDP zinc dialkyldithiophosphate
ZDS zinc depletion syndrome
ZF zero frequency; zinc finger [protein]; zona fasciculata
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 6
ZD Zinc deficient
ZF Zinc finger
ZFP Zinc finger proteins
ZIO Zinc iodide-osmium tetroxide
ZOE Zinc oxide eugenol
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • Newton's method for uric acid
    ´º¿ìư ¿ä»ê Á¤·®¹ý
    »ê¼º ¿°È­Àº ħÀü¹ý¿¡ ÀÇÇØ °£¼· ¹°ÁúÀ» Á¦°ÅÇϰí, û»ê¿°À» È¥ÇÕÇÑ Çǰ˾×À» ºñ¼Ò ÅÖ½ºÅÙ ½Ã¾àÀ» 24½Ã°£ ½Ç¿Â¿¡¼­ ¹ÝÀÀ½ÃÄÑ ºñ»öÇÑ´Ù.
  • Nielsen's method
    ´Ò¼¾ Àΰø È£Èí¹ý
    ȯÀÚ¸¦ ¿ÞÂÊÀ¸·Î ¸ð·Î ´©À̰í, ¸Ó¸®¿¡ º£°³¸¦ ¹ÞÄ£ ´ÙÀ½, ¿ÞÂÊ ÆÈ´Ù¸®¸¦ ¾à°£ ±ÁÈù »óÅ¿¡¼­, ÈäºÎÀÇ ¾çÂÊÀ¸·ÎºÎÅÍ ¾Ð¹ÚÀ» °¡ÇØ È£±â¸¦ ÀÏÀ¸Å°°í, »ó¿ÏÀ» ¾ÕµÚ·Î ¿òÁ÷¿©¼­ Èí±â¸¦ ÀÏÀ¸Å°´Â ¹ý.
  • Nirenstein-Schiff's method
    ´Ï·»½ÃŸÀÎ ½ÃÇÁ ¹ý
    Æé½ÅÀÇ Á¤·®¹ýÀ¸·Î, ´Ü¹éÁúÀ» ÀÏÁ¤ ¿Âµµ¿Í ÀÏÁ¤ ½Ã°£ ³»¿¡ ¼ÒÈ­ÇÏ´Â ÈûÀ¸·Î½á ¿ª°¡¸¦ ÆÇÁ¤ÇÏ´Â ¹æ¹ýÀÌ´Ù.
  • Nissl's method
    ´Ï½½ ¿°»ö¹ý
    ½Å°æ ¼¼Æ÷ °ú¸³ÀÇ ¿°»ö¹ýÀ¸·Î, 90% ¾ËÄڿ÷ΠÁ¶Á÷À» °íÁ¤Çϰí, ´Ï½½ ¿°»ö¾×À¸·Î ¿°»öÇÑ ÈÄ 10% ¾Æ´Ò¸° ¾ËÄڿ÷ΠŻ»öÇÏ´Â ¹ý.
  • one probe method
    ´ÜÀÏ Å½ÃËÀÚ ¹æ½Ä
  • palladiometric method
    ÆÈ¶óµã ¹ý
  • paralleling method
    ÆòÇà¹ý
  • plate dilution method
    ÆòÆÇ Èñ¼®¹ý
  • Plummer's method
    Ç÷¯¸Ó¹ý
    °©»ó¼±Á¾ÀÇ ÃËÁø¹ýÀ¸·Î, Èä°ñ À¯µ¹±ÙÀÇ ÈĹæÀ¸·Î ¿Þ¼ÕÀ» ³ÖµÇ ¾öÁö¼Õ°¡¶ôÀ» ¾ÕÀ¸·Î ÇÏ¿© ¿ì¿±À» ¾Ð¹ÚÇϰí, ¿À¸¥¼ÕÀº ¿Þ¼Õ ÂÊÀ» ÇâÇØ ¾Ð¹ÚÇÏ´Â ¹ý.
  • powder-liquid method
    ºÐ, ¾×¹ý
  • precipitation method
    ħÀü¹ý
  • presaturation method
    ÀüÆ÷È­¹ý
  • quellung method
    ÆØÃ¢¹ý
  • radioactive tracer method
    ¹æ»ç¼º µ¿À§¿ø¼Ò ÃßÀû¹ý
  • reflection method
    ¹Ý»ç¹ý
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
barium sulfate <chemical> Sulfuric acid, barium salt (1:1). A compound used as an X-ray contrast medium that occurs in nature as the mineral barite. It is also used in various manufacturing applications and mixed into heavy concrete to serve as a radiation shield.
Pharmacological action: contrast media.
Chemical name: Sulfuric acid, barium salt (1:1)
(12 Dec 1998)
betanidine sulfate 1-benzyl-2,3-dimethylguanidine;an adrenergic blocking agent used for palliative treatment of hypertension.
Synonym: betanidine sulfate.
(05 Mar 2000)
bethanidine sulfate 1-benzyl-2,3-dimethylguanidine;an adrenergic blocking agent used for palliative treatment of hypertension.
Synonym: betanidine sulfate.
(05 Mar 2000)
bevonium methyl sulfate 2-(hydroxymethyl)-1,1-dimethylpiperidinium methyl sulfate benzylate;an anticholinergic agent.
Synonym: pyribenzyl methyl sulfate.
(05 Mar 2000)
bile acid 3alpha-sulfate sulfohydrolase <enzyme> Used for determination of serum 3alpha-sulfated bile acids; converts 3alpha-sulfated bile acids into 3beta-hydroxy bile acids
Registry number: EC 3.1.6.-
Synonym: 3alpha-sulfated bile acid sulfohydrolase, ba-3s sulfohydrolase
(26 Jun 1999)
bleomycin sulfate An antineoplastic antibiotic obtained from Streptomyces verticillus.
(05 Mar 2000)
butacaine sulfate 3-(Dibutylamino)-1-propanol p-aminobenzoate sulfate;a local anaesthetic.
(05 Mar 2000)
butirosin sulfate <chemical> A water-soluble aminoglycosidic antibiotic complex isolated from fermentation filtrates of bacillus circulans. Two components (a and b) have been separated from the complex. Both are active against many gram-positive and some gram-negative bacteria.
Pharmacological action: antibiotics, aminoglycoside.
(12 Dec 1998)
calcium sulfate <chemical> It exists in an anhydrous form and in various states of hydration: the hemihydrate is plaster of paris, the dihydrate is gypsum. It is used in building materials, as a desiccant, in dentistry as an impression material, cast, or die, and in medicine for immobilizing casts and as a tablet excipient.
Pharmacological action: dental materials, excipient.
Chemical name: Sulfuric acid, calcium salt (1:1)
(12 Dec 1998)
capreomycin sulfate <chemical> Cyclic peptide antibiotic similar to viomycin. It is produced by streptomyces capreolus.
Pharmacological action: antibiotics, antitubercular, antibiotics, peptide.
(12 Dec 1998)
galactocerebroside sulfate sulfatidase <enzyme> Catabolises galactocerebroside sulfatide at a neutral but not at an acidic pH; has no requirement for ATP or magnesium; mw 66-72 kD
Registry number: EC 3.1.6.-
Synonym: neutral sulfatidase, n-sulfatidase
(26 Jun 1999)
magnesium sulfate <chemical> Sulfuric acid magnesium salt (1:1). A small colourless crystal used as an anticonvulsant, a cathartic, and an electrolyte replenisher in the treatment of preeclampsia and eclampsia. It causes direct inhibition of action potential in the myometrial muscle cells. Excitation and contraction are uncoupled, which decreases the frequency and force of contractions.
Pharmacological action: anticonvulsants, cathartic, tocolytic agents.
Chemical name: Sulfuric acid magnesium salt (1:1)
(12 Dec 1998)
paromomycin sulfate A broad spectrum antibiotic produced by Streptomyces rimosus forma paromomycinus; used in the treatment of bacterial enteritis and amoebiasis, and for preoperative suppression of intestinal bacteria.
(05 Mar 2000)
vinblastine sulfate A dimeric alkaloid obtained from Vinca rosea. It arrests mitosis in metaphase (although vincristine is more active in this respect) and exhibits greater antimetabolic activity than does vincristine; used in the treatment of Hodgkin's disease, choriocarcinoma, acute and chronic leukaemias, and other neoplastic diseases; blocks microtubule assembly.
Synonym: vincaleucoblastine.
(05 Mar 2000)
vincristine sulfate A dimeric alkaloid obtained from Vinca rosea; its antineoplastic activity is similar to that of vinblastine, but no cross-resistance develops between these two agents, and it is more useful than vinblastine in lymphocytic lymphosarcoma and acute leukaemia.
Synonym: leurocristine.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 6
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 6
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 6
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 6
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 6
ÅëÇÕ°Ë»ö ¿Ï·á